Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional DosageXiuwen Guan, Binghe Xu, Fei Ma et al.|Frontiers in Oncology|2020Cited by 52
Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancerXiuwen Guan, Fei Ma, Binliang Liu et al.|The Breast|2019Cited by 39
Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysisZongbi Yi, Binghe Xu, Fei Ma et al.|Scientific Reports|2017Cited by 30
Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkersZongbi Yi, Binghe Xu, Binliang Liu et al.|The Breast|2020Cited by 27
The association between early‐onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple‐negative breast cancer patients and some novel autophagy‐related polymorphisms in their genomic DNA: a real‐world studyBinliang Liu, Tao An, Meiying Li et al.|Cancer Communications|2018Cited by 24